APi Group Corporation provides safety and specialty services worldwide. The company offers end-to-end integrated occupancy systems, such as fire protection services; heating, ventilation, and air conditioning solutions; and entry systems, elevators, and escalators, including design, installation, inspection, and service of these integrated systems. It also provides various infrastructure and specialized industrial plant services comprising maintenance and repair of underground electric, gas, water, sewer, and telecommunications infrastructure; engineering and design, fabrication, installation, maintenance service and repair, retrofitting and upgrading, pipeline infrastructure, access and road construction, supporting facilities, and integrity management and maintenance. The company serves commercial, education, healthcare, high tech, industrial, and special-hazard settings, as well as private and public utilities, communications, healthcare, education, transportation, manufacturing, industrial plants and governmental agencies. The company was formerly known as J2 Acquisition Limited and changed its name to APi Group Corporation in October 2019. APi Group Corporation was founded in 1926 and is headquartered in New Brighton, Minnesota.

APi Group Corporation

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Apogee Therapeutics, with a price target of $137.00. According...

BTIG Sticks to Its Buy Rating for Apogee Therapeutics (APGE)

Apollo Gold ( ($TSE:APGO) ) has provided an announcement. Apollo Silver Corp. has been accepted into the U.S. Defense Industrial Base Consortium, a...

Apollo Silver Joins U.S. Defense Industrial Base Consortium to Advance Critical Minerals Supply

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Concentra Group Holdings Parent, Inc. (CON – Researc...

Analysts Are Bullish on These Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Apogee Therapeutics (APGE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fractyl Health, Inc. (GUTS – Research Report), GE Healthcare Tech...

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE)

Apollo Gold ( ($TSE:APGO) ) just unveiled an update. Apollo Silver Corp. has closed the second and final tranche of its upsized non-brokered privat...

Apollo Silver Raises $27.5 Million as Jupiter Asset Management Boosts Stake

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apogee Therapeutics (APGE – Research Report) and Neurocrine (NBIX...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE) and Neurocrine (NBIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apogee Therapeutics (APGE – Research Report) and Sanofi (SNYNF – ...

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Sanofi (OtherSNYNF)

RBC Capital analyst Ashish Sabadra maintained a Buy rating on APi Group today and set a price target of $45.00. Sabadra covers the Financial sector...

RBC Capital Reaffirms Their Buy Rating on APi Group (APG)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE – Research Report) and G...

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)

Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ) has provided an announcement. At the 44th Annual J.P. Morgan Healthcare Conference...

Ascentage Pharma Details 2026 Global Innovation Strategy at J.P. Morgan Healthcare Conference

The latest announcement is out from Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ). On January 6, 2026, Ascentage Pharma Group In...

Ascentage Pharma Wins FDA IND Clearance for BTK Degrader APG-3288 to Enter Global Phase I Trial

In a report released today, Joseph Catanzaro from Mizuho Securities reiterated a Buy rating on Apogee Therapeutics, with a price target of $105.00....

Mizuho Securities Sticks to Their Buy Rating for Apogee Therapeutics (APGE)

Canaccord Genuity analyst Edward Nash maintained a Buy rating on Apogee Therapeutics yesterday and set a price target of $89.00. The company’s shar...

Canaccord Genuity Keeps Their Buy Rating on Apogee Therapeutics (APGE)

In a report released today, from UBS initiated coverage with a Buy rating on Apogee Therapeutics and a price target of $100.00. In addition to UBS,...

UBS Initiates a Buy Rating on Apogee Therapeutics (APGE)

Barclays analyst Julian Mitchell maintained a Buy rating on APi Group today and set a price target of $44.00. Mitchell covers the Industrials secto...

Barclays Sticks to Their Buy Rating for APi Group (APG)

There’s plenty of stock market stories traders will want to keep tabs on in the TipRanks daily wrap-up for Tuesday.


Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

Shares in biotech firm Apogee Therapeutics ($APGE) sank about 5% early Tuesday despite reporting “positive” results from its early-stage human tria...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	APG	$41.95	-0.62%	851.39K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	APG	$41.95	-0.6%	851.39K
3
4
5
6

APG

APG

Dividend Overview

Get APi Group Corporation Data in Excel

Get APi Group Corporation Data in Excel